Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 at the bottom of the page, signaling a minor maintenance update. It does not modify the study details or other substantive content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a maintenance update to the page's underlying tooling. This change does not modify the study content or its presentation.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.6.4 is now listed, replacing Revision: v3.6.3. This indicates a minor release of the page software rather than changes to study content or functionality.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision updated from v3.6.2 to v3.6.3, signaling a new build of the page. This update does not alter the study details or data presented.SummaryDifference0.1%

- Check78 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the page's underlying system. No substantive changes to study information or visible content are indicated by this patch.SummaryDifference0.1%

- Check92 days agoChange DetectedRecruitment status now shows the study is not enrolling participants. The page also received minor navigation and formatting adjustments, including new help sections and a standardization of the Intervention/Treatment label and revision history.SummaryDifference0.4%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.